X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Chloride, Potassium
2. Slow-k
1. 7447-40-7
2. Sylvite
3. Klotrix
4. Enseal
5. Slow-k
6. Klor-con
7. Muriate Of Potash
8. Neobakasal
9. Potassium Monochloride
10. Chlorvescent
11. Kalitabs
12. Kaochlor
13. Potavescent
14. Kloren
15. Pfiklor
16. Rekawan
17. Chloropotassuril
18. Kcl-retard Zyma
19. Klor-lyte
20. K-contin
21. Kay Ciel
22. Monopotassium Chloride
23. K-lease
24. Kaon Cl
25. Kaon-cl
26. Micro-k
27. Potassium Chloride (kcl)
28. Chloride Of Potash
29. K-lor
30. K-tab
31. Ten-k
32. Kay-em
33. Potassiumchloride
34. Kaliumchlorid
35. Micro-k Ls
36. Kali Muriaticum
37. Emplets Potassium Chloride
38. Kaon-cl 10
39. Potassium;chloride
40. Sylvite (kcl)
41. Kaon Cl-10
42. Micro-k 10
43. Kcl
44. Potassium Chloride Solution
45. Sylvine
46. K+10
47. Chloride (as Potassium)
48. Steropotassium
49. Acronitol
50. Kaliduron
51. Kaliglutol
52. Kalilente
53. Kaliolite
54. Miopotasio
55. Durekal
56. Durules
57. Kadalex
58. Kalcorid
59. Kaleorid
60. Kalinorm
61. Kalipor
62. Kalipoz
63. Keylyte
64. Klorvess
65. Mfcd00011360
66. Nsc-77368
67. Potasion
68. Potasol
69. Celeka
70. Enpott
71. 14336-88-0
72. Natural Sylvite
73. Kato
74. Kalium Duriles
75. Kalium Durules
76. Kalium-durettes
77. Rekawan Retard
78. Kalium Retard
79. Lento-kalium
80. Peter-kal
81. Kalitrans Retard
82. Potassium Muriate
83. Durules-k
84. Kalium-r
85. Kay-ciel
86. Repone K
87. Diffu-k
88. Kalinor-retard P
89. Kalium Sr
90. Lento-k
91. Super K
92. Ultra K Chlor
93. Ultra-k-chlor
94. Kcl Retard
95. Addi-k
96. Cena-k
97. Ins No.508
98. K-care
99. K-grad
100. K-norm
101. Span-k
102. Clor-k-zaf
103. Potassium Chloride,ar,99.5%
104. Micro-k Extentcaps
105. Plus Kalium Retard
106. Potassium Chloride, Acs Reagent
107. Infalyte
108. Kayciel
109. Apo-k
110. Chebi:32588
111. K Tab
112. K-dur
113. K-lyte Cl
114. K-sol
115. Kay-cee-l
116. Leo-k
117. Micro-kalium Retard
118. Rum-k
119. Ins-508
120. Nu-k
121. Slow-k Tablets
122. Kalinorm Depottab
123. Tripotassium Trichloride
124. 660yq98i10
125. K+8
126. K-sr
127. Chlorid Draselny [czech]
128. Super K (salt)
129. Kaon-cl Tabs
130. Kalium S.r.
131. Klor-con M20
132. Chlorid Draselny
133. Potassium Cl
134. E 508
135. E-508
136. Buffer Solution, Ph 2.00
137. Buffer Solution, Ph 9.00
138. Potassium Chloride [jan]
139. Potassium Chloride, Ultra Dry
140. Klor-con M10
141. Klor-con M15
142. Potassium Chloride (k3cl3)
143. Caswell No. 686
144. Epiklor
145. Kali Chloratum
146. Kali Chloridum
147. Potassium, Reference Standard Solution
148. Potassii Chloridum
149. Klotrix (tn)
150. Klor-con (tn)
151. Ccris 1962
152. Klor-con 10
153. K-10
154. Hsdb 1252
155. Kaon-cl (tn)
156. K-dur (tn)
157. Potassium Chloride 10meq In Plastic Container
158. Potassium Thallium Chloride (ktlcl)
159. [kcl]
160. Einecs 231-211-8
161. Nsc 77368
162. Epa Pesticide Chemical Code 013904
163. Kcl (tn)
164. Potassium Chloride In Plastic Container
165. Kalii Chloridum
166. Potassium Chloride [usp:jan]
167. Unii-660yq98i10
168. Potassium Chloride 30meq In Plastic Container
169. Potassium Chloride 40meq In Plastic Container
170. Potassium Chloride Salt
171. Potassium Chloride,(s)
172. Potassium (as Chloride)
173. Potassium Chloride 20meq In Plastic Container
174. Wln: Ka G
175. Ec 231-211-8
176. Buffer Solution, Ph 1.01
177. Potassium(i) Chloride
178. B1653 [langual]
179. Isa (ionic Strength Adjustment Solution: 1 M Kcl)
180. Kali Muriaticum [hpus]
181. Potassium Chloride, Food Grade
182. Potassium Chloride [ii]
183. Potassium Chloride [mi]
184. Chembl1200731
185. Dtxsid5021178
186. Potassium Chloride (fru Grade)
187. Potassium Chloride [fcc]
188. Potassium Chloride Solution, 1m
189. Buffer Concentrate, Ph 10.01
190. Potassium Chloride (jp17/usp)
191. Potassium Chloride [hsdb]
192. Potassium Chloride [inci]
193. Potassium Chloride Solution, 1 M
194. Potassium Chloride Solution, 20%
195. Potassium Chloride, Optical Grade
196. Potassium Chloride [vandf]
197. Potassium Chloride, Lr, >=99%
198. Potassium Chloride [mart.]
199. Amy37139
200. Cs-b1714
201. Hy-y0537
202. Nsc77368
203. Potassium Chloride [usp-rs]
204. Potassium Chloride [who-dd]
205. Potassium Chloride [who-ip]
206. Potassium Chloride, Acs, 99.5%
207. Str03715
208. Potassium Chloride - Drilling Grade
209. Potassium Chloride Solution, 3.3 M
210. Potassium Chloride, Ar, >=99.5%
211. Akos015902779
212. Akos024438069
213. Akos024457458
214. Potassium Chloride 3m Aqueous Solution
215. Potassium Chloride Solution, 0.01 M
216. Db00761
217. Kalii Chloridum [who-ip Latin]
218. Potassium Chloride [orange Book]
219. Potassium Chloride, 1m Aqueous Solution
220. Chloride (as Potassium) [vandf]
221. Potassium (as Chloride) [vandf]
222. Potassium Chloride [ep Monograph]
223. Potassium Chloride, Bioxtra, >=99.0%
224. Potassium Chloride, Bp, Ph. Eur. Grade
225. E508
226. Potassium Chloride [usp Monograph]
227. Tham-e Component Potassium Chloride
228. Potassium Chloride Biochemical Grade = 99%
229. B7289
230. Ft-0645107
231. P1757
232. Potassium Chloride, Acs Reagent, >=99.0%
233. Potassium Chloride, P.a., 99.0-100.5%
234. Halflytely Component Potassium Chloride
235. Potassium Chloride (technical Grade, Type A)
236. Potassium Chloride (technical Grade, Type B)
237. Potassium Chloride Component Of Tham-e
238. Potassium Chloride, 99.997% (metals Basis)
239. Tis-u-sol Component Potassium Chloride
240. D02060
241. Potassium Chloride, Bioultra, >=99.5% (at)
242. Potassium Chloride, Reagentplus(r), >=99.0%
243. Potassium Chloride Component Of Halflytely
244. Potassium Chloride Component Of Tis-u-sol
245. Potassium Chloride Solution, In H2o (saturated)
246. Potassium Chloride, 99.999% Trace Metals Basis
247. Potassium Chloride, Saj First Grade, >=99.0%
248. Potassium Chloride, Tested According To Ph.eur.
249. Potassium Chloride, Trace Metals Grade 99.99%
250. Potassium Chloride, >=99.99% Trace Metals Basis
251. Potassium Chloride, 0.85m, Conductivity Standard
252. Potassium Chloride, Acs Reagent, 99.0-100.5%
253. Potassium Chloride, Jis Special Grade, >=99.5%
254. Potassium Chloride, Spectroscopy Grade, Ultrapure
255. Potassium Chloride, Usp Special, 99.0-100.5%
256. Potassium Chloride, Vetec(tm) Reagent Grade, 99%
257. Q184630
258. Potassium Chloride, 0.005m, Conductivity Standard
259. Potassium Chloride, 0.007m, Conductivity Standard
260. Potassium Chloride, 0.010m, Conductivity Standard
261. Potassium Chloride, 0.0145m, Conductivity Standard
262. Potassium Chloride, 0.0375m, Conductivity Standard
263. Potassium Chloride, 0.0765m, Conductivity Standard
264. Potassium Chloride, 0.117m, Conductivity Standard
265. Potassium Chloride, 0.159m, Conductivity Standard
266. Potassium Chloride, 1m Aqueous Solution, Rnase Free
267. Potassium Chloride, Puriss. P.a., >=99.5% (at)
268. Potassium Chloride Solution, Bioultra, ~3 M In H2o
269. Potassium Chloride, 0.00017m, Conductivity Standard
270. Potassium Chloride, 0.00068m, Conductivity Standard
271. Potassium Chloride, For Molecular Biology, >=99.0%
272. Potassium Chloride, ~0.000027m, Conductivity Standard
273. Potassium Chloride, Meets Ep, Usp Testing Specifications
274. Isa (ionic Strength Adjustment Solution: 1 M Kcl), 1 M Kcl
275. Potassium Chloride Crystal Optic Disc, 13mm X 2mm, Unpolished
276. Potassium Chloride Crystal Optic Disc, 25mm X 5mm, Unpolished
277. Potassium Chloride Crystal Optic Disc, 32mm X 3mm, Unpolished
278. Potassium Chloride Solution, Standard, Solution (volumetric), 1.0 M
279. Potassium Chloride, Bioultra, For Molecular Biology, >=99.5% (at)
280. Potassium Standard For Aas, Ready-to-use, Traceable To Bam, In H2o
281. Potassium Chloride Crystal Optic Disc, 13mm X 1mm, Polished Both Sides
282. Potassium Chloride Crystal Optic Disc, 13mm X 2mm, Polished Both Sides
283. Potassium Chloride Crystal Optic Disc, 22mm X 4mm, Polished Both Sides
284. Potassium Chloride Crystal Optic Disc, 25mm X 2mm, Polished Both Sides
285. Potassium Chloride Crystal Optic Disc, 25mm X 4mm, Polished Both Sides
286. Potassium Chloride Crystal Optic Disc, 32mm X 3mm, Polished Both Sides
287. Potassium Chloride Crystal Optic Disc, 38mm X 6mm, Polished Both Sides
288. Potassium Chloride Crystal Optic Rectangle, 30mm X 15mm X 4mm, Unpolished
289. Potassium Chloride Crystal Optic Rectangle, 41mm X 23mm X 6mm, Unpolished
290. Potassium Chloride Solution, Bioultra, For Molecular Biology, ~1 M In H2o
291. Potassium Chloride, Anhydrous, Beads, -10 Mesh, 99.99% Trace Metals Basis
292. Potassium Chloride, Nist Srm 1655, Kcl (cr) For Solution Calorimetry
293. Potassium Chloride, United States Pharmacopeia (usp) Reference Standard
294. Potassium Chloride Crystal Optic Disc, 32mm X 3mm (drilled), Polished Both Sides
295. Potassium Chloride Crystal Optic Rectangle, 30mm X 15mm X 4mm, Polished Both Sides
296. Potassium Chloride Crystal Optic Rectangle, 38.5mm X 19.5mm X 4mm, Unpolished
297. Potassium Chloride Solution, 0.075 M, Sterile-filtered, Bioxtra, Suitable For Cell Culture
298. Potassium Chloride Solution, Conductance Standard A Acc. To Iso 7888, 0.1 M Kcl
299. Potassium Chloride Solution, Conductance Standard B Acc. To Iso 7888, 0.01 M Kcl
300. Potassium Chloride Solution, Conductance Standard C Acc. To Iso 7888, 0.001 M Kcl
301. Potassium Chloride Solution, Conductivity 11.67 Ms/cm At 20 C, Analytical Standard
302. Potassium Chloride, Anhydrous, Beads, -10 Mesh, 99.999% Trace Metals Basis
303. Potassium Chloride, Anhydrous, Free-flowing, Redi-dri(tm), Acs Reagent, >=99%
304. Potassium Chloride, Anhydrous, Free-flowing, Redi-dri(tm), Reagentplus(r), >=99%
305. Potassium Chloride, Pharmaceutical Secondary Standard; Certified Reference Material
306. Potassium Chloride, Puriss. P.a., Reag. Iso, Reag. Ph. Eur., 99.5-100.5%
307. Potassium Atomic Spectroscopy Standard Concentrate 1.00 G K, For 1 L Standard Solution, 1.00 G/l, Analytical Standard
308. Potassium Atomic Spectroscopy Standard Concentrate 10.00 G K, 10.00 G/l, For 1l Standard Solution, Analytical Standard
309. Potassium Chloride Crystal Optic Rectangle, 30mm X 15mm X 4mm, (drilled), Polished Both Sides
310. Potassium Chloride Crystal Optic Rectangle, 38.5mm X 19.5mm X 4mm, (drilled), Polished Both Sides
311. Potassium Chloride, Powder, Bioreagent, Suitable For Cell Culture, Suitable For Insect Cell Culture, >=99.0%
312. Potassium Chloride, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, Fcc, E508, 99-100.5% (at), <=0.0001% Al
313. Potassium Standard Solution, Suitable For Atomic Absorption Spectrometry, 1000 Ppm K+, 1 Mg/ml K+
| Molecular Weight | 74.55 g/mol |
|---|---|
| Molecular Formula | ClK |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 73.9325592 g/mol |
| Monoisotopic Mass | 73.9325592 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 2 |
| Formal Charge | 0 |
| Complexity | 2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 26 | |
|---|---|
| Drug Name | Klor-con |
| PubMed Health | Potassium Chloride (By mouth) |
| Drug Classes | Nutriceutical, Potassium Supplement |
| Drug Label | Klor-ConM20 is an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in a tablet.Klor-ConM15 is an immediately dispersing ex... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 10meq; 8meq |
| Market Status | Prescription |
| Company | Upsher-smith Labs |
| 2 of 26 | |
|---|---|
| Drug Name | Klor-con m10 |
| Drug Label | Klor-Con M20 is an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in a tablet.Klor-Con M15 is an immediately dispers... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 10meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 3 of 26 | |
|---|---|
| Drug Name | Klor-con m15 |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 15meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 4 of 26 | |
|---|---|
| Drug Name | Klor-con m20 |
| Drug Label | Micro-K Extencaps Capsules and Micro-K 10 Extencaps Capsules are oral dosage forms of microencapsulated potassium chloride containing 600 and 750 mg, respectively, of potassium chloride, USP, equivalent to 8 and 10 mEq of potassium, respectiv... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 20meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 5 of 26 | |
|---|---|
| Drug Name | K-tab |
| PubMed Health | Potassium Chloride (By mouth) |
| Drug Classes | Nutriceutical, Potassium Supplement |
| Drug Label | K-TAB (potassium chloride extended-release tablets) is a solid oral dosage form of potassium chloride containing 750 mg of potassium chloride, USP, equivalent to 10 mEq of potassium in a film-coated (not enteric-coated), wax matrix tablet. This formu... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 20meq; 10meq |
| Market Status | Prescription |
| Company | Abbvie |
| 6 of 26 | |
|---|---|
| Drug Name | Micro-k |
| Drug Label | Micro-K Extencaps Capsules and Micro-K 10 Extencaps Capsules are oral dosage forms of microencapsulated potassium chloride containing 600 and 750 mg, respectively, of potassium chloride, USP, equivalent to 8 and 10 mEq of potassium, respectiv... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 8meq |
| Market Status | Prescription |
| Company | Nesher Pharms |
| 7 of 26 | |
|---|---|
| Drug Name | Micro-k 10 |
| Drug Label | Potassium Chloride for Injection Concentrate, USP, is a sterile, nonpyrogenic, concentrated solution of potassium chloride, USP in water for injection administered by intravenous infusion only after dilution in a larger volume of fluid. They are prov... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 10meq |
| Market Status | Prescription |
| Company | Nesher Pharms |
| 8 of 26 | |
|---|---|
| Drug Name | Potassium chloride |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release |
| Route | oral; Injection; Oral |
| Strength | 10.0meq; 20meq; 3meq/ml; 8.0meq; 10meq; 8meq; 2meq/ml |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Anchen Pharms; Amneal Pharms; Hospira; Actavis Labs Fl; Eurand; Baxter Hlthcare; Paddock; Fresenius Kabi Usa; B Braun; Esi Lederle; Elan Pharm |
| 9 of 26 | |
|---|---|
| Drug Name | Potassium chloride 10meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 14.9mg/ml; 746mg/100ml; 745mg/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 10 of 26 | |
|---|---|
| Drug Name | Potassium chloride 20meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 1.49gm/100ml; 29.8mg/ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 11 of 26 | |
|---|---|
| Drug Name | Potassium chloride 30meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2.24gm/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 12 of 26 | |
|---|---|
| Drug Name | Potassium chloride 40meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2.98gm/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 13 of 26 | |
|---|---|
| Drug Name | Potassium chloride in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2meq/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa |
| 14 of 26 | |
|---|---|
| Drug Name | Klor-con |
| PubMed Health | Potassium Chloride (By mouth) |
| Drug Classes | Nutriceutical, Potassium Supplement |
| Drug Label | Klor-ConM20 is an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in a tablet.Klor-ConM15 is an immediately dispersing ex... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 10meq; 8meq |
| Market Status | Prescription |
| Company | Upsher-smith Labs |
| 15 of 26 | |
|---|---|
| Drug Name | Klor-con m10 |
| Drug Label | Klor-Con M20 is an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in a tablet.Klor-Con M15 is an immediately dispers... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 10meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 16 of 26 | |
|---|---|
| Drug Name | Klor-con m15 |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 15meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 17 of 26 | |
|---|---|
| Drug Name | Klor-con m20 |
| Drug Label | Micro-K Extencaps Capsules and Micro-K 10 Extencaps Capsules are oral dosage forms of microencapsulated potassium chloride containing 600 and 750 mg, respectively, of potassium chloride, USP, equivalent to 8 and 10 mEq of potassium, respectiv... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 20meq |
| Market Status | Prescription |
| Company | Upsher Smith Labs |
| 18 of 26 | |
|---|---|
| Drug Name | K-tab |
| PubMed Health | Potassium Chloride (By mouth) |
| Drug Classes | Nutriceutical, Potassium Supplement |
| Drug Label | K-TAB (potassium chloride extended-release tablets) is a solid oral dosage form of potassium chloride containing 750 mg of potassium chloride, USP, equivalent to 10 mEq of potassium in a film-coated (not enteric-coated), wax matrix tablet. This formu... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 20meq; 10meq |
| Market Status | Prescription |
| Company | Abbvie |
| 19 of 26 | |
|---|---|
| Drug Name | Micro-k |
| Drug Label | Micro-K Extencaps Capsules and Micro-K 10 Extencaps Capsules are oral dosage forms of microencapsulated potassium chloride containing 600 and 750 mg, respectively, of potassium chloride, USP, equivalent to 8 and 10 mEq of potassium, respectiv... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 8meq |
| Market Status | Prescription |
| Company | Nesher Pharms |
| 20 of 26 | |
|---|---|
| Drug Name | Micro-k 10 |
| Drug Label | Potassium Chloride for Injection Concentrate, USP, is a sterile, nonpyrogenic, concentrated solution of potassium chloride, USP in water for injection administered by intravenous infusion only after dilution in a larger volume of fluid. They are prov... |
| Active Ingredient | Potassium chloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 10meq |
| Market Status | Prescription |
| Company | Nesher Pharms |
| 21 of 26 | |
|---|---|
| Drug Name | Potassium chloride |
| Active Ingredient | Potassium chloride |
| Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release |
| Route | oral; Injection; Oral |
| Strength | 10.0meq; 20meq; 3meq/ml; 8.0meq; 10meq; 8meq; 2meq/ml |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Anchen Pharms; Amneal Pharms; Hospira; Actavis Labs Fl; Eurand; Baxter Hlthcare; Paddock; Fresenius Kabi Usa; B Braun; Esi Lederle; Elan Pharm |
| 22 of 26 | |
|---|---|
| Drug Name | Potassium chloride 10meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 14.9mg/ml; 746mg/100ml; 745mg/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 23 of 26 | |
|---|---|
| Drug Name | Potassium chloride 20meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 1.49gm/100ml; 29.8mg/ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 24 of 26 | |
|---|---|
| Drug Name | Potassium chloride 30meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2.24gm/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 25 of 26 | |
|---|---|
| Drug Name | Potassium chloride 40meq in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2.98gm/100ml |
| Market Status | Prescription |
| Company | Hospira; Baxter Hlthcare |
| 26 of 26 | |
|---|---|
| Drug Name | Potassium chloride in plastic container |
| Active Ingredient | Potassium chloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2meq/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa |
The oral dose of 10% potassium chloride elixir (Kay Ciel) required to reverse thiazide-induced hypokalemia was determined in 15 patients with essential hypertension who were taking Esidrix (hydrochlorothiazide) in a dose of 50 mg. twice daily. Each patient had maintained a serum potassium concentration of at least 0.5 meq./l. less than duplicate control values (mean decreases, 0.62 meq./l.) for at least 2 months during therapy with hydrochlorothiazide, 50 mg. twice daily. Potassium chloride 10% elixir was administered in a total daily dose of 40 mg. with bimonthly increments to 60 mg., 80 mg. and 100 mg. while the thiazide administration was maintained. The serum potassium deficit was repleted to 75% in 12 of the 15 patients. In 8 of the 12, this was accomplished with 40 mg. potassium chloride daily, and in 4, with 60 mg. daily. The latter dose is recommended in patients with thiazide-induced hypokalemia.
Schwartz AB and Swartz CD; J. Am. Med. Assoc.; VOL 230 P702-704 (1974)
Thirty-six adult patients with cardiovascular disorders were enrolled in an open 12 week study to evaluate the efficacy, safety and patient acceptance of sustained-release potassium chloride (Klotrix; I) tablets, at a dosage of 1.8 g daily. These patients were on an established regimen of potassium wasting diuretics as part of their treatment for hypertension or arteriosclerotic heart disease, and all were receiving an oral potassium supplement. On the first day of the study, the previously used oral potassium supplement was discontinued and I substituted. Serum potassium levels remained normal and other laboratory parameters did not change significantly as a result of the changeover from the previous potassium supplement to I. However, side effects occurred less frequently with I, and while more than half the patients commented on the bad taste or bad aftertaste of their previous supplement, no such comments were recorded for I. Patient acceptance of I was high, and 87% of the patients who completed the study expressed a preference for I over their previous oral potassium supplement.
Tarpley EL and Cordano A; Curr Ther Res Clin Exp.; VOL 21 ISS P282-288 (1977).
Medication (vet): as oral or parenteral source of potassium... in cattle it has been successfully used iv for "creeper cows"...& in cases of debilitating diarrhea. 1% Level in feed reduces incidence of urolithiasis in lambs, & orally...for...feeder calves...as electrolyle source.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 472
Potassium chloride is of value for the relief of symptoms of hypokaliemic periodic paralysis, and the symptoms of Meniere's disease. Daily intake of potassium decreases the risk of stroke-associated mortality.
OECD; Screening Information Data Set (SIDS) Initial Assessment Report for SIDS Initial Assessment Meeting (SIAM) 13, Potassium Chloride (CAS 7447-40-7) (November 2001). Available from, as of March 23, 2015. https://www.inchem.org/pages/sids.html
For more Therapeutic Uses (Complete) data for POTASSIUM CHLORIDE (16 total), please visit the HSDB record page.
The cardiac effects of hyperkalemia are principal toxic effects of potassium. They are mediated through changes in the intra/extracellular potassium ratio, which alters cardiac conduction. With no underlying conduction defects a transient increase in cardiac conduction occurs with potassium concentrations above 7 mmol/L, but a profound depression occurs when concentrations rise over 8.0 mmol/L. One of the effects of hyperkalemia is the depolarisation of cardiac muscle, which interferes with normal contractility. Potassium chloride exerts a direct irritant effect on the gastrointestinal mucosa.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
Local pain and inflammation may result from subcutaneous injection). Skin rash has rarely been reported with potassium preparations.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
The initial signs of poisoning are generally gastrointestinal: nausea, vomiting and diarrhea. These symptoms can develop into abdominal pain and eventually paralytic ileus. Gastrointestinal perforation after oral exposure can occur. Bleeding and perforation have been reported in patients receiving solid forms of potassium chloride.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
A number of neuromuscular effects can be seen, usually with potassium concentrations of 7.0 mmol/L or higher. General weakness and flaccidity precede ascending paralysis. Tremor, paresthesias, decreased vibration perception and proprioception can be seen, but the sensory function is usually intact. Dysarthria and dysphagia may occur.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
For more Drug Warnings (Complete) data for POTASSIUM CHLORIDE (8 total), please visit the HSDB record page.
3. 3= Moderately toxic: probably oral lethal dose (human) 0.5-5 g/kg, between 1 oz and 1 pint (or 1 lb) for 70 kg person (150 lb).
Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. II-124
For use as an electrolyte replenisher and in the treatment of hypokalemia.
FDA Label
The potassium ion is in the principle intracellular cation of most body tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity, the transmission of nerve impulses, the contraction of cardiac, skeletal and smooth muscle, and the maintenance of normal renal function. The intracellular concentration of potassium is approximately 150 to 160 mEq per liter. The normal adult plasma concentration is 3.5 to 5 mEq per liter. An active ion transport system maintains this gradient across the plasma membrane. Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. The usual dietary intake of potassium is 50 to 100 mEq per day. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake. Such depletion usually develops as a consequence of therapy with diuretics, primarily or secondary hyperaldosteronism, diabetic ketoacidosis, or inadequate replacement of potassium in patients on prolonged parenteral nutrition. Depletion can develop rapidly with severe diarrhea, especially if associated with vomiting. Potassium depletion due to these causes is usually accompanied by concomitant loss of chloride and is manifested by hypokalemia and metabolic alkalosis. Potassium depletion may produce weakness, fatigue, disturbances of cardiac rhythm (primarily ectopic beats), prominent U-waves in the electrocardiogram, and, in advanced cases, flaccid paralysis and/or impaired ability to concentrate urine. If potassium depletion associated with metabolic alkalosis cannot be managed by correcting the fundamental cause of the deficiency, e.g., where the patient requires long-term diuretic therapy, supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels. In rare circumstances (e.g., patients with renal tubular acidosis) potassium depletion may be associated with metabolic acidosis and hyperchloremia. In such patients, potassium replacement should be accomplished with potassium salts other than the chloride, such as potassium bicarbonate, potassium citrate, potassium acetate, or potassium gluconate.
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12B - Potassium
A12BA - Potassium
A12BA01 - Potassium chloride
B - Blood and blood forming organs
B05 - Blood substitutes and perfusion solutions
B05X - I.v. solution additives
B05XA - Electrolyte solutions
B05XA01 - Potassium chloride
Absorption
Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine.
Route of Elimination
Potassium is a normal dietary constituent and, under steady-state conditions, the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake.
At steady state continuous excretion of potassium chloride in the urine and faeces equals the daily intake.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
Orally and intravenously administered potassium chloride reaches an equilibrium between the extracellular fluid and intracellular space.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
Almost all orally administered potassium chloride is absorbed. The peak level and its occurrence time after ingestion depend on the preparation administered.
International Programme on Chemical Safety (IPCS); Poisons Information Monograph: Potassium Chloride (PIM 430) (1992) Available from, as of November 15, 2006: https://www.inchem.org/documents/pims/pharm/potasscl.htm
About 90% of the ingested dose of potassium is absorbed by passive diffusion in the membrane of the upper intestine. Potassium is distributed to all tissues where it is the principal intracellular cation. Insulin, acid-base status, aldosterone, and adrenergic activity regulate cellular uptake of potassium. /potassium/
OECD; Screening Information Data Set (SIDS) Initial Assessment Report for SIDS Initial Assessment Meeting (SIAM) 13, Potassium Chloride (CAS 7447-40-7) (November 2001). Available from, as of March 23, 2015. https://www.inchem.org/pages/sids.html
For more Absorption, Distribution and Excretion (Complete) data for POTASSIUM CHLORIDE (8 total), please visit the HSDB record page.
Supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels.
K+ is the principal cation mediating the osmotic balance of the body fluids. In animals, the maintenance of normal cell volume and pressure depends on Na+ and K+ pumping. The K+/Na+ separation has allowed for evolution of reversible transmembrane electrical potentials essential for nerve and muscle action in animals, and both potassium and chloride are important in transmission of nerve impulses to the muscle fibers. /postasium/
OECD; Screening INformation Data Set (SIDS) Initial Assessment Report for SIDS Initial Assessment Meeting (SIAM) 13, Potassium Chloride (CAS 7447-40-7) (November 2001). Available from, as of March 23, 2015. https://www.inchem.org/pages/sids.html
The reported mutagenic effect of KCl most probably results from a disruption of osmotic balance of cells with a subsequent interference with chromosomal stability. This may result in the clastogenic effects (DNA breakage and chromosome structural instability) due to K+ effects on sequestering of Mg2+ ions required for normal maintenance of chromatin integrity. Other chemicals may also exert such effect (e.g. NaCl, sucrose).
OECD; Screening INformation Data Set (SIDS) Initial Assessment Report for SIDS Initial Assessment Meeting (SIAM) 13, Potassium Chloride (CAS 7447-40-7) (November 2001). Available from, as of March 23, 2015. https://www.inchem.org/pages/sids.html
Potassium and chloride is also important in the regulation of the acid-base balance of the body. Potassium is the principal base in tissues of blood cells, and Cl maintains electrochemical neutrality by anion exchange with bicarbonate (the chloride shift) in the CO2 transport in the blood red cells.
OECD; Screening INformation Data Set (SIDS) Initial Assessment Report for SIDS Initial Assessment Meeting (SIAM) 13, Potassium Chloride (CAS 7447-40-7) (November 2001). Available from, as of March 23, 2015. https://www.inchem.org/pages/sids.html
Market Place
